Skip to main content
Top
Published in: European Radiology 9/2020

01-09-2020 | Ultrasound | Hepatobiliary-Pancreas

Differentiation of regenerative nodule, dysplastic nodule, and small hepatocellular carcinoma in cirrhotic patients: a contrast-enhanced ultrasound–based multivariable model analysis

Authors: Yu Duan, Xiaoyan Xie, Qian Li, Nathaniel Mercaldo, Anthony E. Samir, Ming Kuang, Manxia Lin

Published in: European Radiology | Issue 9/2020

Login to get access

Abstract

Objective

To develop a contrast-enhanced ultrasound (CEUS)–based model for differentiating cirrhotic liver lesions and for active surveillance of hepatocellular carcinoma (HCC).

Methods

Patients with focal liver lesions (FLLs) with biopsy/resection-proven pathology and pre-procedure CEUS were enrolled from our institution between January 2011 and November 2014. Univariable and multivariable regression models were constructed using qualitative CEUS features and/or contrast arrival time ratio (CATR). The optimism-adjusted Harrell’s generalized concordance index (CH) was used to quantify the discriminatory ability of each CEUS feature and model.

Results

A total of 149 patients (113 men and 36 women) with 162 FLLs were enrolled with mean age 53.4 ± 12.7 years. A 0.1-unit reduction in CATR was associated with a 68% increase in the odds of having a higher nodule ranking (RN < DN < small HCC) (OR, 0.32; 95% CI, 0.20–0.50, p < .001). Arterial phase hypoenhancement and isoenhancement were inversely associated with a higher nodule ranking compared to hyperenhancement. Late-phase isoenhancement was associated with lower odds of a higher nodule ranking. The CEUS + CATR model (CH 0.92, 0.89–0.95) provided greater discriminatory ability when compared to the CATR model (ΔCH 0.09, 0.04–0.13, p < .001) and the CEUS model (ΔCH 0.03, 0.01–0.05, p = .02).

Conclusions

Our results provide preliminary evidence that multivariable regression model constructed using both qualitative CEUS features and CATR provides the greatest discriminatory ability to differentiate RN, DN, and small HCC in patients with cirrhosis, and might allow for active surveillance of the progression of cirrhotic liver lesions.

Key Points

• Proportional odds logistic regression models based on qualitative CEUS features and/or CAT R can be used for differentiating cirrhotic liver lesions and for active surveillance of HCC.
• The reduction of CAT R (RN < DN < small HCC) was strongly associated with high-risk cirrhotic liver nodules.
• Inclusion of CAT R in the CEUS prediction model significantly improved its performance for cirrhotic liver lesions risk-stratification.
Appendix
Available only for authorised users
Literature
1.
go back to reference European Association for the Study of the Liver (2018) EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 69:182–236CrossRef European Association for the Study of the Liver (2018) EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 69:182–236CrossRef
2.
go back to reference Trevisani F, Cantarini MC, Wands JR, Bernardi M (2008) Recent advances in the natural history of hepatocellular carcinoma. Carcinogenesis 29:1299–1305CrossRef Trevisani F, Cantarini MC, Wands JR, Bernardi M (2008) Recent advances in the natural history of hepatocellular carcinoma. Carcinogenesis 29:1299–1305CrossRef
3.
go back to reference Bruix J, Sherman M (2005) Management of hepatocellular carcinoma. Hepatology 42:1208–1236CrossRef Bruix J, Sherman M (2005) Management of hepatocellular carcinoma. Hepatology 42:1208–1236CrossRef
4.
go back to reference Choi JY, Lee JM, Sirlin CB (2014) CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects. Radiology 272:635–654CrossRef Choi JY, Lee JM, Sirlin CB (2014) CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects. Radiology 272:635–654CrossRef
5.
go back to reference Quaia E, Degobbis F, Tona G, Mosconi E, Bertolotto M, Pozzi Mucelli R (2004) Differential patterns of contrast enhancement in different focal liver lesions after injection of the microbubble US contrast agent SonoVue. Radiol Med 107:155–165PubMed Quaia E, Degobbis F, Tona G, Mosconi E, Bertolotto M, Pozzi Mucelli R (2004) Differential patterns of contrast enhancement in different focal liver lesions after injection of the microbubble US contrast agent SonoVue. Radiol Med 107:155–165PubMed
6.
go back to reference Takahashi M, Maruyama H, Shimada T et al (2013) Characterization of hepatic lesions (</= 30 mm) with liver-specific contrast agents: a comparison between ultrasound and magnetic resonance imaging. Eur J Radiol 82:75–84CrossRef Takahashi M, Maruyama H, Shimada T et al (2013) Characterization of hepatic lesions (</= 30 mm) with liver-specific contrast agents: a comparison between ultrasound and magnetic resonance imaging. Eur J Radiol 82:75–84CrossRef
7.
go back to reference Sugimoto K, Moriyasu F, Shiraishi J et al (2012) Assessment of arterial hypervascularity of hepatocellular carcinoma: comparison of contrast-enhanced US and gadoxetate disodium-enhanced MR imaging. Eur Radiol 22:1205–1213CrossRef Sugimoto K, Moriyasu F, Shiraishi J et al (2012) Assessment of arterial hypervascularity of hepatocellular carcinoma: comparison of contrast-enhanced US and gadoxetate disodium-enhanced MR imaging. Eur Radiol 22:1205–1213CrossRef
8.
go back to reference Heimbach JK, Kulik LM, Finn RS et al (2018) AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology 67:358–380CrossRef Heimbach JK, Kulik LM, Finn RS et al (2018) AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology 67:358–380CrossRef
9.
go back to reference Omata M, Lesmana LA, Tateishi R et al (2010) Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int 4:439–474CrossRef Omata M, Lesmana LA, Tateishi R et al (2010) Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int 4:439–474CrossRef
10.
go back to reference Wu W, Chen MH, Sun M, Yan K, Yang W, Li JY (2012) Contrast-enhanced ultrasound of hepatocarcinogenesis in liver cirrhosis. Chin Med J (Engl) 125:3104–3109 Wu W, Chen MH, Sun M, Yan K, Yang W, Li JY (2012) Contrast-enhanced ultrasound of hepatocarcinogenesis in liver cirrhosis. Chin Med J (Engl) 125:3104–3109
11.
go back to reference Wu W, Chen M, Yan K et al (2015) Evaluation of contrast-enhanced ultrasound for diagnosis of dysplastic nodules with a focus of hepatocellular carcinoma in liver cirrhosis patients. Chin J Cancer Res 27:83–89PubMedPubMedCentral Wu W, Chen M, Yan K et al (2015) Evaluation of contrast-enhanced ultrasound for diagnosis of dysplastic nodules with a focus of hepatocellular carcinoma in liver cirrhosis patients. Chin J Cancer Res 27:83–89PubMedPubMedCentral
12.
go back to reference Jang HJ, Kim TK, Wilson SR (2009) Small nodules (1-2 cm) in liver cirrhosis: characterization with contrast-enhanced ultrasound. Eur J Radiol 72:418–424CrossRef Jang HJ, Kim TK, Wilson SR (2009) Small nodules (1-2 cm) in liver cirrhosis: characterization with contrast-enhanced ultrasound. Eur J Radiol 72:418–424CrossRef
13.
go back to reference Kojiro M (2004) Focus on dysplastic nodules and early hepatocellular carcinoma: an Eastern point of view. Liver Transpl 10:S3–S8CrossRef Kojiro M (2004) Focus on dysplastic nodules and early hepatocellular carcinoma: an Eastern point of view. Liver Transpl 10:S3–S8CrossRef
14.
go back to reference International Consensus Group for Hepatocellular Neoplasia (2009) Pathologic diagnosis of early hepatocellular carcinoma: a report of the International Consensus Group for Hepatocellular Neoplasia. Hepatology 49:658–664CrossRef International Consensus Group for Hepatocellular Neoplasia (2009) Pathologic diagnosis of early hepatocellular carcinoma: a report of the International Consensus Group for Hepatocellular Neoplasia. Hepatology 49:658–664CrossRef
15.
go back to reference Yin S, Cui Q, Yan K et al (2017) Effect of contrast-enhanced ultrasound on differential diagnosis of intrahepatic cholangiocarcinoma and arterial phase enhanced hepatic inflammatory lesions. Chin J Cancer Res 29:272–280CrossRef Yin S, Cui Q, Yan K et al (2017) Effect of contrast-enhanced ultrasound on differential diagnosis of intrahepatic cholangiocarcinoma and arterial phase enhanced hepatic inflammatory lesions. Chin J Cancer Res 29:272–280CrossRef
16.
go back to reference Nasr P, Hilliges A, Thorelius L, Kechagias S, Ekstedt M (2016) Contrast-enhanced ultrasonography could be a non-invasive method for differentiating none or mild from severe fibrosis in patients with biopsy proven non-alcoholic fatty liver disease. Scand J Gastroenterol 51:1126–1132CrossRef Nasr P, Hilliges A, Thorelius L, Kechagias S, Ekstedt M (2016) Contrast-enhanced ultrasonography could be a non-invasive method for differentiating none or mild from severe fibrosis in patients with biopsy proven non-alcoholic fatty liver disease. Scand J Gastroenterol 51:1126–1132CrossRef
17.
go back to reference Shiozawa K, Watanabe M, Kikuchi Y, Kudo T, Maruyama K, Sumino Y (2012) Evaluation of sorafenib for hepatocellular carcinoma by contrast-enhanced ultrasonography: a pilot study. World J Gastroenterol 18:5753–5758CrossRef Shiozawa K, Watanabe M, Kikuchi Y, Kudo T, Maruyama K, Sumino Y (2012) Evaluation of sorafenib for hepatocellular carcinoma by contrast-enhanced ultrasonography: a pilot study. World J Gastroenterol 18:5753–5758CrossRef
18.
go back to reference Lei Z, Li J, Wu D et al (2016) Nomogram for preoperative estimation of microvascular invasion risk in hepatitis B virus-related hepatocellular carcinoma within the Milan criteria. JAMA Surg 151:356–363CrossRef Lei Z, Li J, Wu D et al (2016) Nomogram for preoperative estimation of microvascular invasion risk in hepatitis B virus-related hepatocellular carcinoma within the Milan criteria. JAMA Surg 151:356–363CrossRef
19.
go back to reference Xu HX, Lu MD, Liu GJ et al (2006) Imaging of peripheral cholangiocarcinoma with low-mechanical index contrast-enhanced sonography and SonoVue: initial experience. J Ultrasound Med 25:23–33CrossRef Xu HX, Lu MD, Liu GJ et al (2006) Imaging of peripheral cholangiocarcinoma with low-mechanical index contrast-enhanced sonography and SonoVue: initial experience. J Ultrasound Med 25:23–33CrossRef
20.
go back to reference Jang HJ, Kim TK, Burns PN, Wilson SR (2007) Enhancement patterns of hepatocellular carcinoma at contrast-enhanced US: comparison with histologic differentiation. Radiology 244:898–906CrossRef Jang HJ, Kim TK, Burns PN, Wilson SR (2007) Enhancement patterns of hepatocellular carcinoma at contrast-enhanced US: comparison with histologic differentiation. Radiology 244:898–906CrossRef
21.
go back to reference Scheuer PJ (1991) Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 13:372–374CrossRef Scheuer PJ (1991) Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 13:372–374CrossRef
22.
go back to reference International Working Party (1995) Terminology of nodular hepatocellular lesions. Hepatology 22:983–993CrossRef International Working Party (1995) Terminology of nodular hepatocellular lesions. Hepatology 22:983–993CrossRef
23.
go back to reference Harrell FE (2015) Regression modeling strategies, 2nd edn. Springer International Publishing, New YorkCrossRef Harrell FE (2015) Regression modeling strategies, 2nd edn. Springer International Publishing, New YorkCrossRef
24.
go back to reference Yee TW (2010) The VGAM package for categorical data analysis. J Stat Softw 32:1–34CrossRef Yee TW (2010) The VGAM package for categorical data analysis. J Stat Softw 32:1–34CrossRef
25.
go back to reference Van Calster B, Van Belle V, Vergouwe Y, Steyerberg EW (2012) Discrimination ability of prediction models for ordinal outcomes: relationships between existing measures and a new measure. Biom J 54:674–685CrossRef Van Calster B, Van Belle V, Vergouwe Y, Steyerberg EW (2012) Discrimination ability of prediction models for ordinal outcomes: relationships between existing measures and a new measure. Biom J 54:674–685CrossRef
26.
go back to reference Frank E. Harrell J (2017) rms: regression modeling strategies., R package version 5.1–1 Frank E. Harrell J (2017) rms: regression modeling strategies., R package version 5.1–1
27.
go back to reference Canty A, Ripley B (2017) Bootstrap R (S-Plus) functions., R package version 1.3–20 Canty A, Ripley B (2017) Bootstrap R (S-Plus) functions., R package version 1.3–20
28.
go back to reference Park YN, Yang CP, Fernandez GJ, Cubukcu O, Thung SN, Theise ND (1998) Neoangiogenesis and sinusoidal “capillarization” in dysplastic nodules of the liver. Am J Surg Pathol 22:656–662CrossRef Park YN, Yang CP, Fernandez GJ, Cubukcu O, Thung SN, Theise ND (1998) Neoangiogenesis and sinusoidal “capillarization” in dysplastic nodules of the liver. Am J Surg Pathol 22:656–662CrossRef
29.
go back to reference Nicolau C, Catala V, Vilana R et al (2004) Evaluation of hepatocellular carcinoma using SonoVue, a second generation ultrasound contrast agent: correlation with cellular differentiation. Eur Radiol 14:1092–1099CrossRef Nicolau C, Catala V, Vilana R et al (2004) Evaluation of hepatocellular carcinoma using SonoVue, a second generation ultrasound contrast agent: correlation with cellular differentiation. Eur Radiol 14:1092–1099CrossRef
30.
go back to reference Li JP, Feng GL, Li DQ et al (2016) Detection and differentiation of early hepatocellular carcinoma from cirrhosis using CT perfusion in a rat liver model. Hepatobiliary Pancreat Dis Int 15:612–618CrossRef Li JP, Feng GL, Li DQ et al (2016) Detection and differentiation of early hepatocellular carcinoma from cirrhosis using CT perfusion in a rat liver model. Hepatobiliary Pancreat Dis Int 15:612–618CrossRef
31.
go back to reference Zheng RQ, Zhang B, Kudo M, Sakaguchi Y (2005) Hemodynamic and morphologic changes of peripheral hepatic vasculature in cirrhotic liver disease: a preliminary study using contrast-enhanced coded phase inversion harmonic ultrasonography. World J Gastroenterol 11:6348–6353CrossRef Zheng RQ, Zhang B, Kudo M, Sakaguchi Y (2005) Hemodynamic and morphologic changes of peripheral hepatic vasculature in cirrhotic liver disease: a preliminary study using contrast-enhanced coded phase inversion harmonic ultrasonography. World J Gastroenterol 11:6348–6353CrossRef
32.
go back to reference Kono Y, Lyshchik A, Cosgrove D et al (2017) Contrast Enhanced Ultrasound (CEUS) Liver Imaging Reporting and Data System (LI-RADS): the official version by the American College of Radiology (ACR). Ultraschall Med 38:85–86CrossRef Kono Y, Lyshchik A, Cosgrove D et al (2017) Contrast Enhanced Ultrasound (CEUS) Liver Imaging Reporting and Data System (LI-RADS): the official version by the American College of Radiology (ACR). Ultraschall Med 38:85–86CrossRef
33.
go back to reference Claudon M, Dietrich CF, Choi BI et al (2013) Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver--update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultraschall Med 34:11–29CrossRef Claudon M, Dietrich CF, Choi BI et al (2013) Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver--update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultraschall Med 34:11–29CrossRef
34.
go back to reference Iwazawa J, Ohue S, Hashimoto N, Abe H, Hamuro M, Mitani T (2010) Detection of hepatocellular carcinoma: comparison of angiographic C-arm CT and MDCT. AJR Am J Roentgenol 195:882–887CrossRef Iwazawa J, Ohue S, Hashimoto N, Abe H, Hamuro M, Mitani T (2010) Detection of hepatocellular carcinoma: comparison of angiographic C-arm CT and MDCT. AJR Am J Roentgenol 195:882–887CrossRef
35.
go back to reference Renzulli M, Biselli M, Brocchi S et al (2018) New hallmark of hepatocellular carcinoma, early hepatocellular carcinoma and high-grade dysplastic nodules on Gd-EOB-DTPA MRI in patients with cirrhosis: a new diagnostic algorithm. Gut 67:1674–1682CrossRef Renzulli M, Biselli M, Brocchi S et al (2018) New hallmark of hepatocellular carcinoma, early hepatocellular carcinoma and high-grade dysplastic nodules on Gd-EOB-DTPA MRI in patients with cirrhosis: a new diagnostic algorithm. Gut 67:1674–1682CrossRef
Metadata
Title
Differentiation of regenerative nodule, dysplastic nodule, and small hepatocellular carcinoma in cirrhotic patients: a contrast-enhanced ultrasound–based multivariable model analysis
Authors
Yu Duan
Xiaoyan Xie
Qian Li
Nathaniel Mercaldo
Anthony E. Samir
Ming Kuang
Manxia Lin
Publication date
01-09-2020
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 9/2020
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-020-06834-5

Other articles of this Issue 9/2020

European Radiology 9/2020 Go to the issue